Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy. (Q51242700)
Jump to navigation
Jump to search
scientific article published on 26 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy. |
scientific article published on 26 March 2014 |
Statements
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy (English)
Sofie Van Binnebeek
Kristof Baete
Bert Vanbilloen
Christelle Terwinghe
Michel Koole
Felix M Mottaghy
Paul M Clement
Luc Mortelmans
Karin Haustermans
Eric Van Cutsem
Alfons Verbruggen
Chris Verslype
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference